(Stockholm, mass production of stem cells): Has raised 90 MSEK in a funding round led by Jens von Bahr and Fredrik Österberg. Also participating is Nordic Angels‘ latest initiative ACAP, which, along with 4 members, has invested 12 million in Cellcolabs. Read more about ACAP below. Cellcolabs is now accelerating its efforts to mass-produce stem cells for the global market.
Do you also want to take part in ACAP’s dealflow?
Nordic Angels is also a co-founder of ACAP, an initiative that filters the top 1-2% of all cases shared among Sweden’s angels and offers a select group of investors, who have specifically expressed interest and commitment, to participate. If you are interested in this, email acap@nordicangels.com for more information.